The price of Vor Biopharma Inc (NASDAQ:VOR) shares last traded on Wall Street fell -6.07% to $2.24.
VOR stock price is now 222.30% away from the 50-day moving average and 153.39% away from the 200-day moving average. The market capitalization of the company currently stands at $280.53M.
With the price target maintained at $3, H.C. Wainwright recently Upgraded its rating from Neutral to Buy for Vor Biopharma Inc (NASDAQ: VOR). On July 26, 2022, Wedbush recently initiated its ‘Outperform’ rating on the stock quoting a target price of $18, while ‘Goldman’ rates the stock as ‘Neutral’
In other news, Robert Ang, Officer bought 214,135 shares of the company’s stock on Jul 15 ’25. The stock was bought for $520,586 at an average price of $2.43. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 10 ’25, Officer Robert Ang bought 596,885 shares of the business’s stock. A total of $1,388,091 was incurred on buying the stock at an average price of $2.33. A total of 48.06% of the company’s stock is owned by insiders.
During the past 12 months, Vor Biopharma Inc has had a low of $0.13 and a high of $3.29. As of last week, the company has a debt-to-equity ratio of 0.47, a current ratio of 3.88, and a quick ratio of 3.88. The fifty day moving average price for VOR is $0.66496 and a two-hundred day moving average price translates $0.87864 for the stock.
The latest earnings results from Vor Biopharma Inc (NASDAQ: VOR) was released for 2025-03-31.
